Form 8-K - Current report:
SEC Accession No. 0000950170-24-122815
Filing Date
2024-11-07
Accepted
2024-11-07 08:00:09
Documents
12
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pepg-20241107.htm   iXBRL 8-K 39284
2 EX-99.1 pepg-ex99_1.htm EX-99.1 92775
  Complete submission text file 0000950170-24-122815.txt   258959

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pepg-20241107.xsd EX-101.SCH 25793
14 EXTRACTED XBRL INSTANCE DOCUMENT pepg-20241107_htm.xml XML 4875
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41374 | Film No.: 241433261
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)